Détail de l'auteur
Auteur M.E. HALLORAN |
Documents disponibles écrits par cet auteur (9)
Ajouter le résultat à ma sélection Faire une suggestion Affiner la recherche
Article
M.E. HALLORAN ; Imjr LONGINI ; Arnold-S MONTO, éd. ; C.J. STRUCHINER ; Stephen-B THACKER, éd. ; Department of Biostatistics. Rollins School of Public Health. Emory University. Atlanta. GA. USA |[BDSP. Notice produite par INIST 3R0xmcLh. Diffusion soumise à autorisation].Article
L.K. DURHAM ; J.D. CLEMENS ; M.E. HALLORAN ; Imjr LONGINI ; A. NIZAM ; M. RAO ; Department of Biostatistics. The Rollins School of Public Health. Emory University. Atlanta GA. USA ; Division of Epidemiology. Statistics. And Prevention. National Institute of Child Health and Human Development. National Institutes of Heath. Bethesda MD. USA |[BDSP. Notice produite par INIST lR0xBS7I. Diffusion soumise à autorisation]. The authors present a nonparametric method for estimating vaccine efficacy as a smooth function of time from vaccine trials. Use of the method requires a minimum of as[...]Article
J. BERTOLLI ; R. FRERICHS ; M.E. HALLORAN ; C. PANGI |[BDSP. Notice produite par INIST nmyR0xRT. Diffusion soumise à autorisation]. Background. Five randomized trials, a follow-up study, and six case-control investigations of BCG vaccine's effectiveness (VE) for preventing leprosy have been conduct[...]Article
M.E. HALLORAN ; Imjr LONGINI ; C.J. STRUCHINER ; Department of Biostatistics. Rollins School of Public Health. Emory University. Atlanta GA. USA |[BDSP. Notice produite par INIST Bc7R0xXd. Diffusion soumise à autorisation]. Vaccine efficacy and effectiveness (VE) are generally measured as 1 minus some measure of relative risk (RR) in the vaccinated group compared with the unvaccinated gro[...]Article
M.E. HALLORAN ; Imjr LONGINI ; C.J. STRUCHINER ; Department of Biostatistics. Rollins School of Public Health. Emory University. Atlanta GA. USA |[BDSP. Notice produite par INIST vR0x7Jq2. Diffusion soumise à autorisation]. The authors consider estimability and interpretation of vaccine efficacy based on time to event data, allowing that some of the population might have a very low probab[...]Article
D.J. MOSURE ; S. BERMAN ; M.E. HALLORAN ; D. KLEINBAUM ; Division of Sexually Transmitted Disease Prevention. Centers for Disease Control and Prevention. Atlanta GA. USA |[BDSP. Notice produite par INIST R0xZx1lM. Diffusion soumise à autorisation]. Screening guidelines recommend testing all sexually active female adolescents for Chlamydia trachomatis during a pelvic examination at each clinic visit. Such criteria[...]Article
[BDSP. Notice produite par INIST R0xfe0pU. Diffusion soumise à autorisation]. Background. Meningococcal disease is still a serious public health problem in many countries. A vaccine produced by Cuba was the first product against B meningococcus [...]Article
M. HABER ; M.E. HALLORAN ; L. WATELET ; Emory univ. Rollins school public health. Dep biostatistics. Atlanta GA. USA |[BDSP. Notice produite par INIST 7R0xq9pb. Diffusion soumise à autorisation]. Background. The protective effect of a vaccine following an outbreak is often measured by the vaccine efficacy statistic, namely one minus the ratio of attack rates in[...]Article
M. HABER ; M.E. HALLORAN ; Imjr LONGINI ; W.A. ORENSTEIN ; Emory univ. Rollins school public health. Dep biostatistics. Atlanta GA. USA |[BDSP. Notice produite par INIST iR0xkiSS. Diffusion soumise à autorisation]. A common source of bias in evaluating vaccine efficacy following a disease outbreak is the presence of persons who had the disease prior to the outbreak. This paper ex[...]